Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000217617 | SCV000270905 | likely benign | not specified | 2012-04-30 | criteria provided, single submitter | clinical testing | p.Thr868Thr in Exon 09 of TECTA: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue, is not located with in the splice consensus sequence, and has been identified in 0.3% (32/10406) of African chromosomes by the Exome Aggregation Consortium (http://exac.broadinstit ute.org/; dbSNP rs139509847). |
Eurofins Ntd Llc |
RCV000217617 | SCV000860277 | likely benign | not specified | 2018-04-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000901954 | SCV001046353 | benign | not provided | 2023-12-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000901954 | SCV001783426 | uncertain significance | not provided | 2020-09-10 | criteria provided, single submitter | clinical testing | In-silico analysis, which includes splice predictors and evolutionary conservation, is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Has not been previously published as pathogenic or benign to our knowledge |